|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Mumps Virus IgM ELISA | Anti-Tocilizumab (Actemra®) ELISA | C4a Des Arg RIA Assay | C-Peptide ELISA Assay | Insulin-like Growth Factor-II (IGF-II) ELISA |
| Citations | | | | | |
| Catalog Number | IB79883 | TM09021 | RK-519 | IB79101 | E30 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | The Mumps Virus IgM ELISA is intended for the determination of IgM class antibodies against Mumps Virus in human serum or plasma (citrate, heparin). For research use only - not for use in diagnostic procedures. | Enzyme immunoassay (ELISA) test kit for the determination of free antibodies directed against the drug Tocilizumab (Actemra®) in serum and plasma. For research use only, not for use in diagnostic procedures. | Radioimmunoassay (RIA) for the determination of human Complement C4a des Arg in human plasma. For research use only, not for use in diagnostic procedures. | Solid phase enzyme immunoassay (ELISA) for the determination of C-Peptide in serum, plasma and urine. For research use only, not for use in diagnostic procedures. | Enzyme immunoassay (ELISA) for the determination of IGF-II in human serum, plasma, urine, saliva, and cell culture supernatants. For research use only, not for use in diagnostic procedures. |
| Detection Target | Soluble Leptin Receptor (sLEP-R) | S100B | Leishmania infantum IgG | Dopamine | Corynebacterium diphtheriae toxin IgG |
| Sample Type | Serum or plasma | Serum | Serum, Blood Plasma | Tissue Homogenates, Dialysates, Urine | Serum, Blood Plasma |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Radio Immuno Assay (RIA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | A cut-off control is used for the interpretation of results. | 0 / 6 to 200 ng/mL | 40 to 1300 ng/mL | 0.2 to 16.0 ng/mL | 0.45 to 9.00 ng/mL |
| Sensitivity | 0.0385 ng/mL | Inquire | 0.91 | 0.25 ng/mL x C (must be multipled by a correction factor dependent on sample volume). | 100% (95% confidence interval: 95.44% - 100%) |
| Assay Time | 1 hr 45 mins (incubation) | 2 hours, 10 min. total incubation time. | 1 hr, 30 mins (incubation) | 1 hr 50 mins (incubation) | 3 hrs (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |